Graham Capital Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.4M Buy
154,051
+61,808
+67% +$564K 0.02% 434
2025
Q1
$733K Buy
92,243
+17,276
+23% +$137K 0.01% 625
2024
Q4
$407K Sell
74,967
-11,651
-13% -$63.3K 0.01% 789
2024
Q3
$625K Buy
86,618
+37,252
+75% +$269K 0.01% 548
2024
Q2
$536K Buy
+49,366
New +$536K 0.01% 539